Pages that link to "Q34562526"

The following pages link to Genomic rearrangements in BRCA1 and BRCA2: A literature review. (Q34562526):

Displaying 40 items.

• Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer (Q27023165) (← links)
• Major influence of repetitive elements on disease-associated copy number variants (CNVs) (Q28078563) (← links)
• BRCA1 and BRCA2 mutations and treatment strategies for breast cancer (Q33894431) (← links)
• A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients (Q34184703) (← links)
• Detection of Genomic Variations in BRCA1 and BRCA2 Genes by Long-Range PCR and Next-Generation Sequencing (Q34198843) (← links)
• Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer (Q34288968) (← links)
• Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes (Q34515308) (← links)
• Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review (Q34530426) (← links)
• Development of cancer-initiating cells and immortalized cells with genomic instability (Q35205699) (← links)
• BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report (Q36029740) (← links)
• Next-generation sequencing in familial breast cancer patients from Lebanon (Q36281775) (← links)
• The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective (Q36322846) (← links)
• Identification of large genomic rearrangement of BRCA1/2 in high risk patients in Korea (Q36325812) (← links)
• Clinical significance of large rearrangements in BRCA1 and BRCA2 (Q36494976) (← links)
• A case of synchronous double primary breast carcinoma and osteosarcoma: Mismatch repair genes mutations as a possible cause for multiple early onset malignant tumors (Q36738982) (← links)
• BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome. (Q37011975) (← links)
• Genetic variation of the brca1 and brca2 genes in macedonian patients (Q37181520) (← links)
• Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry (Q37697025) (← links)
• Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients (Q37746872) (← links)
• Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin (Q37995560) (← links)
• Detection of BRCA1 gross rearrangements by droplet digital PCR. (Q40481841) (← links)
• Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation (Q40674850) (← links)
• Screening for genomic rearrangements at BRCA1 locus in Iranian women with breast cancer using multiplex ligation-dependent probe amplification (Q45792425) (← links)
• Computational identification of micro-structural variations and their proteogenomic consequences in cancer (Q47264953) (← links)
• An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice (Q47351280) (← links)
• Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome. (Q48268585) (← links)
• Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome (Q50645287) (← links)
• [BRCA diagnostics of ovarian cancer : Molecular tumor testing since the introduction of PARP inhibitor therapy]. (Q53465543) (← links)
• A novel method to detect the Mexican founder mutation BRCA1 ex9‑12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan® probes (Q57173171) (← links)
• mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea (Q57212483) (← links)
• Molecular Diagnostics in Clinical Oncology (Q58700723) (← links)
• Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility (Q58930584) (← links)
• Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era (Q64387026) (← links)
• Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women. (Q64941413) (← links)
• Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing (Q87646062) (← links)
• Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer (Q88722973) (← links)
• Screening, diagnosis and genetic study of breast cancer patients in Pakistan (Q89736377) (← links)
• DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes (Q90581419) (← links)
• Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank (Q92354869) (← links)
• Breast MRI texture analysis for prediction of BRCA-associated genetic risk (Q98163397) (← links)